A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism.

No abstract is available for this paper.

• Publication year

  1966

• Venue

  British Journal of Pharmacology and Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1476-5381.1966.TB01806.XPMID 5919501PMCID PMC1510768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BLOCKAGE OF SYMPATHETIC BETA-RECEPTORS IN THE MYOCARDIAL CIRCULATION.

  1965cited by this paper
• [ELEDOISIN. CHEMISTRY, PHARMACOLOGY CLINICO-EXPERIMENTAL AND PRELIMINARY THERAPEUTICAL EXPERIENCES].

  1965cited by this paper
• THE EFFECTS OF SYNTHETIC ELEDOISIN ON THE SYSTEMIC AND CORONARY HAEMODYNAMICS AND METABOLISM OF THE INTACT DOG.

  1964cited by this paper
• Preliminary CommunicationsA NEW ADRENERGIC: BETA-RECEPTOR ANTAGONIST

  1964cited by this paper
• A COMPARISON OF THE EFFECTS OF THE PLASMA KININS, BRADYKININ AND KALLIDIN, ON MYOCARDIAL BLOOD FLOW AND METABOLISM.

  1964cited by this paper
• [AN ELECTROMAGNETIC FLOW CLOCK FOR THE MEASUREMENT OF THE CORONARY SINUS OUTFLOW].

  1964cited by this paper
• Vasopressor responses to kallidin, bradykinin and eledoisin in hypotensive rats

  1964cited by this paper
• A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.

  1964cited by this paper
• The effect of bradykinin on blood flow and heat production in the myocardium

  1963cited by this paper
• Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.

  1963cited by this paper
• Effect of the Endecapeptide Eledoisin on the Coronary Blood Flow: Comparison with Nitroglycerin, Bradykinin and Epinephrine in the Dog

  1963cited by this paper
• A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin.

  1963cited by this paper
• The systemic and coronary hemodynamic effects of synthetic bradykinin.

  1963cited by this paper
• [On continuous measurement of oxygen pressure in venous coronary blood].

  1963cited by this paper
• ENZYMATIC STUDIES ON BRADYKININ AND SIMILAR PEPTIDES

  1963cited by this paper
• Studies on the first derivative of the ventricular pressure pulse in man.

  1962cited by this paper
• Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of eledone

  1962cited by this paper
• Effects of Bradykinin on the Systemic and Coronary Vascular Bed of the Intact Dog

  1962cited by this paper
• [Measurement of the oxygen tension in gases and fluids with the Pt-electrode with special reference to measurement in the blood].

  1960cited by this paper
• Active polypeptides derived from plasma proteins.

  1960cited by this paper
• [Oxygen dissociation curves of the blood of mammals (human, rabbit, guinea pig, dog, cat, pig, cow and sheep)].

  1959cited by this paper
• Vasodilatation in the tongue and its relationship to plasma kinin formation

  1958cited by this paper
• Coronary Artery Catheterization in the Intact Dog

  1958cited by this paper
• [Effect of adrenalin, noradrenalin, acetylcholine and vagus stimulation of oxygen saturation of coronary sinus blood, studied with continuous photometric methods].

  1956cited by this paper
• Factors in variation and regulation of coronary blood flow in intact anesthetized dogs.

  1950cited by this paper
• Cardiac oxygen metabolism and control of the coronary circulation.

  1947cited by this paper

• Recent Developments in the Regulation of Kinins

  2014cites this paper
• Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases.

  2014cites this paper
• The kinin system in hypertensive pathophysiology

  2013cites this paper
• Association between the kinin–forming system and cardiovascular pathophysiology

  2012cites this paper
• 8 Kallikrein-kinin system in the heart

  2011cites this paper
• A pharmacological analysis of the possible role of vasoactive mediators in compensatory coronary blood flow.

  2008cites this paper
• Cardiovascular Activities of of the bradykinin system

  2008cites this paper
• Is There a Place for Bradykinin Agonists in Therapy of Cardioscaular Disorders

  2006cites this paper
• Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system.

  2006cites this paper
• The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection

  2006cites this paper
• Does the Kinin System Mediate in Cardiovascular Abnormalities? An Overview

  2003cites this paper
• Effects of pre-, peri-, and postmyocardial infarction treatment with omapatrilat in rats: survival, arrhythmias, ventricular function, and remodeling.

  2003cites this paper
• Integrated Coronary Physiology and Pathophysiology

  2002cites this paper
• Cardiovascular Properties of the Kallikrein-Kinin System

  2002cites this paper
• The Tachykinin Peptide Family

  2002cites this paper
• Kinin receptors and their antagonists as novel therapeutic agents.

  2001cites this paper
• Bradykinin, an Important Mediator of the Cardiovascular Effects of Metallopeptidase Inhibitors: Experimental and Clinical Evidences

  2001cites this paper
• Pathophysiological activities of the kallikrein-kinin system with emphasis on the cardiovascular disorders

  2000cites this paper
• Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion.

  2000cites this paper
• Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice.

  2000cites this paper
• Regulation of the kinin receptors after induction of myocardial infarction: a mini-review.

  2000cites this paper
• Bradykinin B2 receptor as a potential therapeutic target.

  2000cites this paper
• Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

  1999cites this paper
• Bradykinin pretreatment improves ischemia tolerance of the rabbit heart by tyrosine kinase mediated pathways.

  1999cites this paper
• The effect of bradykinin and its antagonist on survival time after coronary artery occlusion in hypertensive rats.

  1999cites this paper
• Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction.

  1999cites this paper
• Effect of bradykinin and its antagonist on survival time after coronary artery occlusion in rats.

  1999cites this paper
• Regional myocardial effects of intracoronary bradykinin in conscious dogs.

  1997cites this paper
• Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.

  1997cites this paper
• The Role of Kinins in the Cardiac Effects of ACE Inhibitors and Myocardial Ischemia

  1997cites this paper
• Effect of bradykinin B2-receptor antagonism on post-ischemic coronary reperfusion.

  1997cites this paper
• Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies

  1996cites this paper
• Kinins in the cardiovascular system.

  1996cites this paper
• Role of kinins in myocardial ischemia.

  1996cites this paper
• Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence.

  1995cites this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cites this paper
• Endothelial protection by converting enzyme inhibitors.

  1994cites this paper
• Cardioprotection by angiotensin converting enzyme inhibitors--the experimental evidence.

  1994cites this paper
• Endogenous myocardial protective (antiarrhythmic) substances.

  1993cites this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cites this paper
• Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia‐induced arrhythmias in anaesthetized dogs

  1991cites this paper
• Identification, purification, and localization of tissue kallikrein in rat heart.

  1990cites this paper
• Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin like activity.

  1989cites this paper
• Coronary vessels contain enzymes that liberate kinin-like vasodilator substances.

  1989cites this paper
• Coronary Circulation

  1987cites this paper
• The tachykinin peptide family

  1981cites this paper
• The early consequences of myocardial ischaemia and their modification.

  1980cites this paper
• The bradykinin-induced coronary vasodilation. evidence for an additional prostacyclin-independent mechanism

  1979cites this paper
• Are prostaglandins involved in the regulation of coronary blood flow? A review of the evidence.

  1978cites this paper
• THE RELEASE OF A CORONARY VASODILATOR METABOLITE FROM THE GUINEA‐PIG ISOLATED PERFUSED HEART STIMULATED BY CATECHOLAMINES, HISTAMINE AND ELECTRICAL PACING AND BY EXPOSURE TO ANOXIA

  1976cites this paper
• Reversal of bradykinin action by a high molecular weight ethylene oxide polymer.

  1974cites this paper
• Effect of Kallikrein on the Cardiovascular System

  1970cites this paper
• An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation

  1970cites this paper
• The Effect of the Kinins on the Cardiovascular System

  1970cites this paper
• [On the mechanism of action of coronary dilators].

  1969cites this paper
• [Pharmacology of some vasoactive agents].

  1968cites this paper
• Chapter 8 Angina Pectoris and Antianginal Agents

  1967cites this paper
• Untersuchungen über die Coronarwirksamkeit des Adenosin und der Adeninnucleotide sowie ihre Beeinflussung durch zwei Substanzen mit starker Coronarwirkung

  1965cites this paper